• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力胸腺切除术:预测因素及长期演变。一项针对46例患者的回顾性研究。

Thymectomy for myasthenia gravis: predictive factors and long term evolution. A retrospective study on 46 patients.

作者信息

Marano E, Pagano G, Persico G, Striano S, Buscaino G A, Campanella G

机构信息

Department of Neurology, School of Medicine, Federico II, University of Naples.

出版信息

Acta Neurol (Napoli). 1993 Aug;15(4):277-88.

PMID:8249671
Abstract

Forty-six patients with myasthenia gravis (MG) underwent transternal thymectomy between 1975 and 1991 and were observed over a long term follow up period (mean 6 years). Surgery was well tolerated and was followed in 32.6% of patients by remission of symptomatology. The severity of symptoms according to the Osserman scale was significantly reduced: slight forms of myasthenia increased soon after thymectomy more frequently than moderate and severe forms. Response to thymectomy at 3 months, according to the Hankins scale, was found to be positive (remission or amelioration of symptoms) in 31/41 patients, and worse in patients with thymoma. Probability of clinical remission and death were both significantly correlated with clinical response at three months after thymectomy. No other preoperatory clinical factor (onset age, sex, initial severity of MG, interval from symptom onset to thymectomy) was found to predict the response to treatment. Preoperatory mediastinic CT had a good reliability (> 85%) in diagnosing thymona, but was rarely able to distinguish between thymic hyperplasia and atrophy.

摘要

1975年至1991年间,46例重症肌无力(MG)患者接受了经胸骨胸腺切除术,并进行了长期随访(平均6年)。手术耐受性良好,32.6%的患者术后症状缓解。根据奥斯erman量表,症状严重程度显著降低:胸腺切除术后,轻度重症肌无力形式比中度和重度形式更频繁地在术后不久增加。根据汉金斯量表,术后3个月时,41例患者中有31例对胸腺切除术的反应为阳性(症状缓解或改善),胸腺瘤患者的反应较差。临床缓解概率和死亡概率均与胸腺切除术后3个月的临床反应显著相关。未发现其他术前临床因素(发病年龄、性别、MG初始严重程度、症状出现至胸腺切除的间隔时间)可预测治疗反应。术前纵隔CT在诊断胸腺瘤方面具有良好的可靠性(>85%),但很少能够区分胸腺增生和萎缩。

相似文献

1
Thymectomy for myasthenia gravis: predictive factors and long term evolution. A retrospective study on 46 patients.重症肌无力胸腺切除术:预测因素及长期演变。一项针对46例患者的回顾性研究。
Acta Neurol (Napoli). 1993 Aug;15(4):277-88.
2
Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.影响重症肌无力经胸骨胸腺切除术预后的因素。
Acta Neurol Scand. 2005 Aug;112(2):108-14. doi: 10.1111/j.1600-0404.2005.00424.x.
3
[Long term effect of thymectomy for patients with myasthenia gravis].[胸腺切除术对重症肌无力患者的长期影响]
Zhonghua Wai Ke Za Zhi. 1999 Jun;37(6):353-4.
4
Transsternal thymectomy for myasthenia gravis: surgical outcome.经胸骨胸腺切除术治疗重症肌无力:手术结果
Ann Thorac Surg. 2006 Jan;81(1):305-8. doi: 10.1016/j.athoracsur.2005.07.050.
5
Thymectomy in the treatment of ocular myasthenia gravis.胸腺切除术治疗眼肌型重症肌无力
J Thorac Cardiovasc Surg. 2001 Sep;122(3):562-8. doi: 10.1067/mtc.2001.116191.
6
Outcome after transsternal radical thymectomy for myasthenia gravis: 14-year review at Ratchaburi Hospital.经胸骨根治性胸腺切除术治疗重症肌无力的疗效:叻丕府医院14年回顾
J Med Assoc Thai. 2004 Nov;87(11):1304-10.
7
[The long-term results of thymectomy for myasthenia gravis].[重症肌无力胸腺切除术的长期结果]
Kyobu Geka. 1995 Mar;48(3):184-9.
8
Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.重症肌无力患者经胸骨扩大胸腺切除术后开始使用他克莫司的经验。
Curr Med Res Opin. 2006 May;22(5):885-95. doi: 10.1185/030079906X104650.
9
[Thymectomy in myasthenia gravis].[重症肌无力的胸腺切除术]
Pol Merkur Lekarski. 2005 Jan;18(103):41-4.
10
[Thymectomy in myasthenia gravis: long-term evolution and predictive factors].[重症肌无力的胸腺切除术:长期演变及预测因素]
Rev Neurol. 2000;30(9):801-6.

引用本文的文献

1
Long-term outcome and quality of life after thymectomy for myasthenia gravis.重症肌无力胸腺切除术后的长期预后及生活质量
Ann Surg. 1996 Aug;224(2):225-32. doi: 10.1097/00000658-199608000-00017.